文献速递类风湿关节炎脊柱关节炎系统性红斑狼疮

风湿性疾病发病前后心血管合并症的风险

Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases.
PubMed 文献 · Semin Arthritis Rheum · 2024-01-26

基于FinnGen研究,纳入2000至2014年确诊的血清阳性或血清阴性类风湿关节炎、强直性脊柱炎、银屑病关节炎、系统性红斑狼疮、原发性干燥综合征或痛风患者,每例按年龄、性别和出生地区匹配20名无风湿病对照。结果显示所有研究的风湿性疾病中「任何心血管疾病」风险比从银屑病关节炎的1.14(95%CI 1.02-1.26)到系统性红斑狼疮的2.05(95%CI 1.67-2.52),系统性红斑狼疮或痛风患者多种心血管合并症风险超过两倍,静脉血栓栓塞在多种风湿病中效应量最高,心血管合并症比值比在风湿病发病前后一年内最高,痛风则在诊断前心血管疾病超额风险尤其高。

要点

  • 所有研究的风湿性疾病中「任何心血管疾病」风险比均升高,系统性红斑狼疮和痛风最高。
  • 系统性红斑狼疮或痛风患者多种心血管合并症风险超过两倍。
  • 静脉血栓栓塞在多种风湿性疾病中效应量最高。

核心结论

  • 所有研究的风湿性疾病中,心血管合并症风险均升高,其中系统性红斑狼疮和痛风风险最高。
  • 心血管疾病风险在风湿病诊断前后即刻最高,提示所有风湿性疾病在病程极早期即存在心血管合并症风险增加。

研究设计与样本

  • 基于FinnGen研究,从医疗登记中识别2000至2014年确诊的血清阳性(n=2368)或血清阴性(n=916)类风湿关节炎、强直性脊柱炎(n=715)、银屑病关节炎(n=923)、系统性红斑狼疮(n=190)、原发性干燥综合征(n=412)或痛风(n=2034)患者。
  • 每例患者按年龄、性别和出生地区匹配20名无任何风湿病的对照。
  • 通过比较患者与对照间七种心血管疾病的患病率计算总体风险比,并使用逻辑回归模型估计风湿病发病前后心血管合并症的比值比。

主要发现

  • 「任何心血管疾病」的风险比从银屑病关节炎的1.14(95%CI 1.02-1.26)到系统性红斑狼疮的2.05(95%CI 1.67-2.52)。
  • 系统性红斑狼疮或痛风患者多种心血管合并症风险超过两倍。
  • 在心血管合并症中,静脉血栓栓塞在多种风湿性疾病中效应量最高。
  • 心血管合并症的比值比在风湿病发病前后一年内最高。
  • 在痛风中,心血管疾病的超额风险在痛风诊断前尤其高。

关键数值与推荐

  • 「任何心血管疾病」风险比:银屑病关节炎1.14(95%CI 1.02-1.26)至系统性红斑狼疮2.05(95%CI 1.67-2.52)。
  • 系统性红斑狼疮或痛风患者多种心血管合并症风险超过两倍。
  • 静脉血栓栓塞在多种风湿性疾病中心血管合并症效应量最高。
  • 心血管合并症比值比在风湿病发病前后一年内最高,痛风在诊断前心血管疾病超额风险尤其高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To elucidate the risk and temporal relationship of cardiovascular (CV) comorbidities in rheumatic diseases. METHODS: Patients in the FinnGen study diagnosed between 2000 and 2014 with seropositive (n = 2368) or seronegative (n = 916) rheumatoid arthritis (RA), ankylosing spondylitis (AS, n = 715), psoriatic arthritis (PsA, n = 923), systemic lupus erythematosus (SLE, n = 190), primary Sjogren's syndrome (pSS, n = 412) or gout (n = 2034) were identified from healthcare registries. Each patient was matched based on age, sex, and birth region with twenty controls without any rheumatic conditions. Overall risk ratios (RR) were calculated by comparing the prevalence of seven CV diseases between patients and controls. Logistic regression models were used for estimating odds ratios (OR) for CV comorbidities before and after the onset of rheumatic diseases. RESULTS: The RR for 'any CVD' varied from 1.14 (95 % confidence interval [CI] 1.02-1.26) in PsA to 2.05 (95 % CI 1.67-2.52) in SLE. Patients with SLE or gout demonstrated over two-fold risks for several CV comorbidities. Among CV comorbidities, venous thromboembolism (VTE) showed the highest effect sizes in several rheumatic diseases. The ORs for CV comorbidities were highest within one year before and/or after the onset of the rheumatic disease. However, in gout the excess risk of CV disease was especially high before gout diagnosis. CONCLUSIONS: The risk of CV comorbidities was elevated in all studied rheumatic diseases, with highest risks observed in SLE and gout. The risk for CV diseases was highest immediately before and/or after rheumatic disease diagnosis, highlighting the increased risk for CV comorbidities across all rheumatic diseases very early on the disease course.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Aaramaa HK, Mars N, Helminen M, et al. Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases. Semin Arthritis Rheum. 2024. PMID: 38308930. doi:10.1016/j.semarthrit.2024.152382

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。